Trial Outcomes & Findings for Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease (NCT NCT03161327)

NCT ID: NCT03161327

Last Updated: 2018-12-11

Results Overview

To evaluate the Positive predictive value of digital ABI in diagnosing PAD using color Doppler ultrasound and 'gold standard' angiography as reference.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

238 participants

Primary outcome timeframe

3 months

Results posted on

2018-12-11

Participant Flow

This study recruited patients from various clinics presenting for appointments not necessarily related to PAD. Patients were asked to complete a screening questionnaire. 1791 patients completed the questionnaire. Patients giving any yes responses were asked if they wanted to participate in the study.

Of the 1791 patients who completed the survey, 238 enrolled in the study (gave consent and completed digital ABI screening).

Participant milestones

Participant milestones
Measure
Patients at Risk for PAD
For those who screened positive by the questionnaire, and signed consent, a digital ABI was performed using QuantaFlo™. For subjects with PAD the referring physician and patient will receive a phone call about the same. He/ she will then be advised any further testing/ referral to IR clinic. For subjects with no evidence of PAD, subject will be informed of results, and no further action taken.
Overall Study
STARTED
238
Overall Study
COMPLETED
238
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Patients at Risk for PAD
n=206 Participants
For those who screened positive by the questionnaire, and signed consent, a digital ABI was performed using QuantaFlo™. For subjects with PAD the referring physician and patient will receive a phone call about the same. He/ she will then be advised any further testing/ referral to IR clinic. For subjects with no evidence of PAD, subject will be informed of results, and no further action taken.
Age, Categorical
<=18 years
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
125 Participants
n=206 Participants
Age, Categorical
>=65 years
81 Participants
n=206 Participants
Age, Continuous
All patients at risk for PAD
59.9 years
STANDARD_DEVIATION 13.1 • n=206 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Age, Continuous
ABI severe risk
68.2 years
STANDARD_DEVIATION 8.5 • n=10 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Age, Continuous
ABI moderate risk
65.6 years
STANDARD_DEVIATION 9.2 • n=15 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Age, Continuous
ABI mild risk
67.1 years
STANDARD_DEVIATION 15.5 • n=19 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
ABI severe risk · Female
6 Participants
n=10 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
ABI severe risk · Male
4 Participants
n=10 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
ABI moderate risk · Female
9 Participants
n=15 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
ABI moderate risk · Male
6 Participants
n=15 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
ABI mild risk · Female
16 Participants
n=19 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
ABI mild risk · Male
3 Participants
n=19 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
All patients at risk for PAD · Female
128 Participants
n=206 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
Sex: Female, Male
All patients at risk for PAD · Male
78 Participants
n=206 Participants • ABI severe, mod and mild risk categories are made up of subjects within the overall at risk for PAD population. These categories are based on ABI results of that population.
diabetic
Pateients at risk for PAD
100 Participants
n=206 Participants
diabetic
ABI severe risk
6 Participants
n=206 Participants
diabetic
ABI moderate risk
11 Participants
n=206 Participants
diabetic
ABI mild risk
11 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 3 months

Population: Positive Predictive Value (PPV)

To evaluate the Positive predictive value of digital ABI in diagnosing PAD using color Doppler ultrasound and 'gold standard' angiography as reference.

Outcome measures

Outcome measures
Measure
ABI Severe Risk
n=10 Participants
Those who screened at risk for PAD on questionnaire, had digital ABI performed, and if ABI \<0.4 , these were described as severe risk for PAD
ABI Moderate-mild Risk
n=34 Participants
Those who screened at risk for PAD on questionnaire, had digital ABI performed, and results were 0.4 to 0.9 , these were at moderate or mild risk for PAD
Positive Predictive Value of Digital ABI in Diagnosing PAD
8 Participants
2 Participants

Adverse Events

ABIABI Using QuantaFlo™

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Keith Pereira

Saint Louis University

Phone: 314-268-5782

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place